Skip to main content
. 2010 Apr 9;12(2):202. doi: 10.1186/bcr2558

Table 1.

The type and frequency of mutations in phosphatidylinositol 3-kinase (PI3K) pathway components in breast cancer

PI3K component Type of mutation Incidence
P110a (PIK3CA) Mutation 27%
P110α (PIK3CA) Amplification 8.7%
P110β (PIK3CB) Amplification 5%
PDPK1 Amplification and overexpression 20%
AKT1 Mutation (E17K) 3.7%
AKT2 Amplification 3%
PTEN Loss of heterozygosity 24.9%
PTEN Mutation 6%